Adsorption and Release Properties of Drug Delivery System Naproxen-SBA-15: Effect of Surface Polarity, Sodium/Acid Drug Form and pH
Source abstract
Abstract
Mesoporous silica SBA-15 was prepared via sol-gel synthesis and functionalized with different types of organosilanes containing various organic functional groups: (3-aminopropyl)triethoxysilane (SBA-15-NH2), (3-mercaptopropyl)triethoxysilane (SBA-15-SH), triethoxymethylsilane (SBA-15-CH3), triethoxyphenylsilane (SBA-15-Ph), and (3-isocynatopropyl)triethoxysilane (SBA-15-NCO). The prepared materials were investigated as drug delivery systems for naproxen. As model drugs, naproxen acid (HNAP) and its sodium salt (NaNAP) were used. Mentioned medicaments belong to the group of non-steroidal anti-inflammatory drugs (NSAIDs). The prepared materials were characterized by different analytical methods such as transmission electron microscopy (TEM), infrared spectroscopy (IR), nitrogen adsorption/desorption analysis (N2), thermogravimetric analysis (TG), 1H, 13C and 23Na solid-state nuclear magnetic resonance spectroscopy (1H, 13C and 23Na ss-NMR). The abovementioned analytical techniques confirmed the successful grafting of functional groups to the SBA-15 surface and the adsorption of drugs after the impregnation process. The BET area values decreased from 927 m2 g−1 for SBA-15 to 408 m2 g−1 for SBA-15-NCO. After drug encapsulation, a more significant decrease in surface area was observed due to the filling of pores with drug molecules, while the most significant decrease was observed for the SBA-15-NH2 material (115 m2 g−1 for NaNAP and 101 m2 g−1 for HNAP). By combining TG and nitrogen adsorption results, the occurrence of functional groups and the affinity of drugs to the carriers’ surface were calculated. The dominant factor was the volume of functional groups and intermolecular interactions. The highest drug affinity values were observed for phenyl and amine-modified materials (SBA-15-Ph = 1.379 μmol m−2 mmol−1 for NaNAP, 1.761 μmol m−2 mmol−1 for HNAP and SBA-15-NH2 = 1.343 μmol m−2 mmol−1 for NaNAP, 1.302 μmol m−2 mmol−1 for HNAP) due to the formation of hydrogen bonds and π-π interactions, respectively. Drug release properties and kinetic studies were performed at t = 37 °C (normal human body temperature) in different media with pH = 2 as simulated human gastric fluid and pH = 7.4, which simulated a physiological environment. Determination of drug release quantity was performed with UV-VIS spectroscopy. The surface polarity, pH and naproxen form influenced the total released amount of drug. In general, naproxen sodium salt has a higher solubility than its acid form, thus significantly affecting drug release from surface-modified SBA-15 materials. Different pH conditions involved surface protonation and formation/disruption of intermolecular interactions, influencing both the release rate and the total released amount of naproxen. Different kinetic models, zero-order, first-order, Higuchi and Hixson–Crowell models, were used to fit the drug release data. According to the obtained experimental results, the drug release rates and mechanisms were determined.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Mesoporous Materials and Catalysis · Supramolecular Self-Assembly in Materials · Analytical Chemistry and Chromatography
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Inorganic Chemistry, Faculty of Science, P. J. Šafárik University, Moyzesova 11, SK-041 01 Košice, Slovakia
Department of NMR Spectroscopy, Institute of Macromolecular Chemistry CAS, Heyrovského nám. 2, CZ-162 06 Prague, Czech Republic
Aix Marseille Univ, CNRS, MADIREL, UMR 7246, 13397 Marseille, France
Funding
the European Regional Development Fund (ERDF)
References (54)
Show source-provided references
1. Nanotechnology Approaches for Global Infectious Diseases10.1038/s41565-021-00866-8 ↗
2. A Review on State of Art and Perspectives of Metal-Organic Frameworks (MOFs) in the Fight against Coronavirus SARS-CoV-210.1080/00958972.2021.1965130 ↗
3. Bergman, M.M. (2020). The World after COVID. World, 1.10.3390/world1010005 ↗
4. Inflammation and Cardiovascular Disease: The Future10.15420/ecr.2020.50 ↗
5. Inflammation-Mediated Angiogenesis in Ischemic Stroke10.3389/fncel.2021.652647 ↗
6. Sagris, M., Oikonomou, E., Antonopoulos, A.S., Siasos, G., Tsioufis, C., and Tousoulis, D. (2021). Inflammatory Mechanisms Contributing to Endothelial Dysfunction. Biomedicines, 9.10.3390/biomedicines9070781 ↗
7. Non-steroidal Anti-inflammatory Drugs: Recent Advances in the Use of Synthetic COX-2 Inhibitors10.1039/D1MD00280E ↗
8. Paek, S.M. (2021). Recent Advances in the Synthesis of Ibuprofen and Naproxen. Molecules, 26.10.3390/molecules26164792 ↗
9. Metal-Organic Framework MIL-101(Fe)-NH2 Functionalized with Different Long-Chain Polyamines as Drug Delivery System10.1016/j.inoche.2018.05.007 ↗
10. Iron-Based Metal–Organic Frameworks in Drug Delivery and Biomedicine10.1021/acsami.0c21486 ↗
11. Metal-Organic Frameworks for Advanced Drug Delivery10.1016/j.apsb.2021.03.019 ↗
12. In Vivo Study of Light-Driven Naproxen Release from Gated Mesoporous Silica Drug Delivery System10.1038/s41598-021-99678-y ↗
13. Mesoporous Silica Nanoparticles for Drug Delivery10.1002/adfm.201902634 ↗
14. Mesoporous Silica Nanoparticles for Pulmonary Drug Delivery10.1016/j.addr.2021.113953 ↗
15. Liposome Composition in Drug Delivery Design, Synthesis, Characterization, and Clinical Application10.1016/j.addr.2021.113851 ↗
16. A Review on Recent Advances in Polymer and Peptide Hydrogels10.1039/C9SM02127B ↗
17. Design of Liposomes as Drug Delivery System for Therapeutic Applications10.1016/j.ijpharm.2021.120571 ↗
18. Update on Nanoparticle-Based Drug Delivery System for Anti-inflammatory Treatment10.3389/fbioe.2021.630352 ↗
19. Comparative Study of Two Silica Mesoporous Materials (SBA-16 and SBA-15) Modified with a Hydroxyapatite Layer for Clindamycin Controlled Delivery10.1016/j.micromeso.2017.07.021 ↗
20. Surface-Activated Fibre-Like SBA-15 as Drug Carriers for Bone Diseases10.1208/s12249-018-1243-5 ↗
21. Biomedical Applications of Mesoporous Silica Nanoparticles as a Drug Delivery Carrier10.1016/j.jddst.2022.103729 ↗
22. Adsorption of Pharmaceuticals Pollutants, Ibuprofen, Acetaminophen, and Streptomycin from the Aqueous Phase Using Amine Functionalized Superparamagnetic Silica Nanocomposite10.1016/j.jclepro.2021.126155 ↗
23. Amine-modified Silica for Removing Aspirin from Water
24. Poly(Amidoamine) Dendrimer-Grafted Porous Hollow Silica Nanoparticles for Enhanced Intracellular Photodynamic Therapy10.1016/j.actbio.2013.01.028 ↗
25. Cationic Poly(ɛ-Caprolactone) Surface Functionalized Mesoporous Silica Nanoparticles and Their Application in Drug Delivery10.1016/j.apsusc.2013.03.168 ↗
26. Zauska, L., Bova, S., Benova, E., Bednarcik, J., Balaz, M., Zelenak, V., Hornebecq, V., and Almasi, M. (2021). Thermosensitive Drug Delivery System SBA-15-PEI for Controlled Release of Nonsteroidal Anti-Inflammatory Drug Diclofenac Sodium Salt: A Comparative Study. Materials, 14.10.3390/ma14081880 ↗
27. Photo-Switchable Nanoporous Silica Supports for Controlled Drug Delivery10.1039/C8NJ00267C ↗
28. A Drug Delivery System Based on Switchable Photo-Controlled p-Coumaric Acid Derivatives Anchored on Mesoporous Silica10.1039/C6TB02040B ↗
29. pH-Responsive Mesoporous Silica Drug Delivery System, Its Biocompatibility and Co-Adsorption/Co-Release of 5-Fluorouracil and Naproxen10.1016/j.apsusc.2021.150011 ↗
30. Adsorption Properties, the pH-Sensitive Release of 5-Fluorouracil and Cytotoxicity Studies of Mesoporous Silica Drug Delivery Matrix
31. Construction of a pH-Responsive Drug Delivery Platform Based on the Hybrid of Mesoporous Silica and Chitosan10.1016/j.jscs.2020.11.007 ↗
32. Pollen-like Silica Nanoparticles as a Nanocarrier for Tumor Targeted and pH-Responsive Drug Delivery10.1016/j.talanta.2021.122402 ↗
33. Synthesis of Temperature/pH Dual-Responsive Mesoporous Silica Nanoparticles by Surface Modification and Radical Polymerization for Anti-Cancer Drug Delivery10.1016/j.colsurfa.2021.126719 ↗
34. Heating of Samples Induced by Fast Magic-Angle Spinning10.1016/S0926-2040(00)00061-8 ↗
35. Physisorption of Gases, with Special Reference to the Evaluation of Surface Area and Pore Size Distribution (IUPAC Technical Report)10.1515/pac-2014-1117 ↗
36. Cytotoxicity Study and Influence of SBA-15 Surface Polarity and pH on Adsorption and Release Properties of Anticancer Agent Pemetrexed
37. Solubility of Naproxen in Several Organic Solvents at Different Temperatures10.1016/j.fluid.2007.03.029 ↗
38. Structural Diversity of Solid Dispersions of Acetylsalicylic Acid as Seen by Solid-State NMR10.1021/mp400495h ↗
39. Exploring the Molecular-Level Architecture of the Active Compounds in Liquisolid Drug Delivery Systems Based on Mesoporous Silica Particles: Old Tricks for New Challenges10.1021/acs.molpharmaceut.7b00167 ↗
40. Determining the Crystal Structures of Peptide Analogs of Boronic Acid in the Absence of Single Crystals: Intricate Motifs of Ixazomib Citrate Revealed by XRPD Guided by Ss-NMR10.1021/acs.cgd.8b00402 ↗
41. Efficient Strategy for Determining the Atomic-Resolution Structure of Micro- and Nanocrystalline Solids within Polymeric Microbeads: Domain-Edited NMR Crystallography10.1021/acs.macromol.8b00392 ↗
42. On the Solid-State NMR Spectra of Naproxen10.1016/j.cplett.2014.11.031 ↗
43. Thermal Solvent-Free Method of Loading of Pharmaceutical Cocrystals into the Pores of Silica Particles: A Case of Naproxen/Picolinamide Cocrystal10.1021/acs.jpcc.6b05302 ↗
44. Sodium-23 Solid-State Nuclear Magnetic Resonance of Commercial Sodium Naproxen and Its Solvates10.1002/jps.23196 ↗
45. Strong Intermolecular Ring Current Influence on 1H Chemical Shifts in Two Crystalline Forms of Naproxen: A Combined Solid-State NMR and DFT Study10.1021/jp4044946 ↗
46. Synthesis of Mesoporous Hollow Silica Nanospheres Using Polymeric Micelles as Template and Their Application as a Drug-Delivery Carrier10.1039/c3dt51267c ↗
47. Mesoporous Silica Nanoparticles for Stimuli-Responsive Controlled Drug Delivery: Advances, Challenges, and Outlook10.2147/IJN.S117495 ↗
48. Enhancement of Anti-Neoplastic Effects of Cuminaldehyde against Breast Cancer via Mesoporous Silica Nanoparticle Based Targeted Drug Delivery System10.1016/j.lfs.2022.120525 ↗
49. Influences of Novel Microwave Drying on Dissolution of New Formulated Naproxen Sodium10.1039/C8RA02106F ↗
50. Thermodynamic Quantities Relative to Solution Processes of Naproxen in Aqueous Media at pH 1.2 and 7.410.1080/00319100600889715 ↗
51. Determination of Saturated Solubility of Naproxen Using UV Visible Spectrophotometer10.5958/0974-360X.2015.00134.1 ↗
52. Ordered Cubic Nanoporous Silica Support MCM-48 for Delivery of Poorly Soluble Drug Indomethacin10.1016/j.apsusc.2018.02.260 ↗
53. Giasafaki, D., Andriotis, E.G., Bouropoulos, N., Theodoroula, N.F., Vizirianakis, I.S., Steriotis, T., Charalambopoulou, G., and Fatouros, D.G. (2021). Oral Drug Delivery Systems Based on Ordered Mesoporous Silica Nanoparticles for Modulating the Release of Aprepitant. Int. J. Mol. Sci., 22.10.3390/ijms22041896 ↗
54. In-depth Insights into Mathematical Characteristics, Selection Criteria and Common Mistakes of Adsorption Kinetic Models: A Critical Review